Literature DB >> 36212265

131I SUCCESSFULLY TREATED A CASE OF HYPERTHYROIDISM AFTER ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION.

J Ge1, J Wang2, H Liu3, R Wan1, X Yao1.   

Abstract

Hematopoietic stem cell transplantation (HSCT) is an effective treatment for various types of hereditary hematologic disease, hematological malignancy, primary immunodeficiency and metabolic disease. Thyroid dysfunction is a common complication of HSCT, which situation is mainly manifested as hypothyroidism and rarely as hyperthyroidism. This report presents a 28-year-old man who developed hyperthyroidism 9 years after sibling allogeneic HSCT, which was most likely caused by chronic GVHD. In the meantime, the patient also suffered from liver dysfunction and pancytopenia, for which he was inappropriate to take antithyroid drugs (ATD) for treatment of hyperthyroidism. The patient was orally administered 259 MBq 131I, an individualized dose. The symptoms of hyperthyroidism were mitigated by 131I treatment. ©2022 Acta Endocrinologica (Buc).

Entities:  

Keywords:  131I; Hematopoietic Stem Cell Transplantation; Hyperthyroidism; graft versus host disease

Year:  2022        PMID： 36212265      PMCID： PMC9512369          DOI： 10.4183/aeb.2022.238

Source DB:  PubMed          Journal:  Acta Endocrinol (Buchar)        ISSN： 1841-0987            Impact factor:   1.104


  13 in total

1.  Graves disease after bone marrow transplantation.

Authors:  A Takeshita; K Shinjo; R Ohno
Journal:  Ann Intern Med       Date:  1999-07-20       Impact factor: 25.391

2.  Thyrotoxicosis after matched unrelated bone marrow transplantation.

Authors:  Ruth Tatevossian; Jo C Blair; Piers N Plowman; Martin O Savage; Ananth Gouri Shankar
Journal:  J Pediatr Hematol Oncol       Date:  2004-08       Impact factor: 1.289

3.  Appearance of thyroid stimulating and blocking immunoglobulins after bone marrow transplantation: presentation of two contrasting cases.

Authors:  Ikuo Yamamori; Tadaharu Kanie; Naoko Maeda; Yoshihisa Kodera; Takaharu Matsuyama; Haruhiko Hasegawa
Journal:  Endocr J       Date:  2004-08       Impact factor: 2.349

Review 4.  Pathophysiology of Chronic Graft-versus-Host Disease and Therapeutic Targets.

Authors:  Robert Zeiser; Bruce R Blazar
Journal:  N Engl J Med       Date:  2017-12-28       Impact factor: 91.245

5.  Adoptive autoimmune hyperthyroidism following allogeneic stem cell transplantation from an HLA-identical sibling with Graves' disease.

Authors:  G A Berisso; M T van Lint; A Bacigalupo; A M Marmont
Journal:  Bone Marrow Transplant       Date:  1999-05       Impact factor: 5.483

6.  Autoimmune thyroid dysfunction after hematopoietic stem cell transplantation.

Authors:  W Y Au; A K W Lie; A W C Kung; R Liang; B R Hawkins; Y L Kwong
Journal:  Bone Marrow Transplant       Date:  2005-02       Impact factor: 5.483

Review 7.  Immune reconstitution syndrome and the thyroid.

Authors:  Anthony Weetman
Journal:  Best Pract Res Clin Endocrinol Metab       Date:  2009-12       Impact factor: 4.690

8.  Cytomegalovirus reactivation triggers the late onset of hyperthyroidism after autologous peripheral blood transplantation.

Authors:  Satoko Oka; Kazuo Ono; Masaharu Nohgawa
Journal:  Leuk Res Rep       Date:  2018-11-22

9.  Autoimmune thyroid disease following hematopoietic stem cell transplantation in childhood cancer survivors.

Authors:  Shunsuke Shimazaki; Itsuro Kazukawa; Masanori Minagawa
Journal:  Clin Pediatr Endocrinol       Date:  2021-12-16

10.  Hyperthyroidism After Allogeneic Hematopoietic Stem Cell Transplantation: A Report of Four Cases.

Authors:  Erdal Sağ; Nazlı Gönç; Ayfer Alikaşifoğlu; Barış Kuşkonmaz; Duygu Uçkan; Alev Özön; Nurgün Kandemir
Journal:  J Clin Res Pediatr Endocrinol       Date:  2015-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.